Jianhua Zheng | Diagnostic of Tuberculosis | Research Excellence Award

Published on by Global Diseases Research

Prof. Jianhua Zheng | Diagnostic of Tuberculosis | Research Excellence Award 

Professor | Peking Union Medical College | China

Prof. Jianhua Zheng is a distinguished researcher at the Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, recognized for his impactful contributions to infectious disease research and translational immunology. With 25 peer-reviewed publications and over 322 citations across 290 citing documents, his work reflects consistent scholarly influence in pathogen biology, immune mechanisms, and diagnostic innovation. Prof. Zheng’s research portfolio spans high-priority global health challenges, including SARS-CoV-2 variant immunology and tuberculosis biomarker discovery. His recent open-access publications—such as the development of a broadly neutralizing antibody effective against multiple SARS-CoV-2 Omicron sub-variants and integrated neutrophil proteomic–transcriptomic profiling for TB diagnosis—demonstrate his commitment to advancing precision medicine and public health solutions. He frequently collaborates with multidisciplinary teams, reflected in more than 100 co-authors, indicating a strong network across molecular biology, clinical research, and computational sciences. Prof. Zheng’s work bridges basic science with clinical application, generating insights that support vaccine development, therapeutic antibody engineering, and early diagnostic strategy design. Through rigorous methodology, open-access dissemination, and global collaborations, his research contributes meaningfully to strengthening infectious disease surveillance, improving patient outcomes, and enhancing preparedness for emerging pathogens. His sustained scholarly productivity and growing citation impact underscore his role as a leading scientist shaping contemporary biomedical research and contributing to international efforts in disease control and health security.

Profiles: Scopus 

Featured Publications

1. Chen, Z., Feng, L., Wang, L., Zhang, L., Zheng, B., Fu, H., Li, F., Liu, L., Lv, Q., Deng, R., Xu, Y., Hu, Y., Zheng, J., Qin, C., Bao, L., Wang, X., & Jin, Q. (2025). A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Signal Transduction and Targeted Therapy, 10, 14.

2. Yang, J., Lv, Z., Liu, L., Zhang, H., Hu, J., Geng, X., Xin, H., Liu, Z., Gao, L., Zhang, X., Xu, Y., Liu, R., Jin, Q., & Zheng, J. (2025). Peripheral blood neutrophil proteomic profiling with transcriptomic data integration reveals biomarkers for tuberculosis infection diagnosis. EBioMedicine, 120, 105945. https://doi.org/10.1016/j.ebiom.2025.105945 Cited by: [not yet available / very recent

3. Liu, L., Xu, D., Chen, F., Cai, S., Wei, J., Deng, J., Zheng, J., Jin, Q., & Lun, W. (2023). Identification of potential biomarkers for diagnosis of syphilis from the cerebrospinal fluid based on untargeted metabolomic analysis. Molecular Omics, 19(6), 484–491.

4. Zheng, J., Liu, L., Wei, C., Liu, B., & Jin, Q. (2022). Characterization of O-mannosylated proteins profiling in Bacillus Calmette-Guérin via gel-based and gel-free approaches. IUBMB Life, 74(3), 221–234.

5. Deng, J., Liu, L., Yang, Q., Wei, C., Zhang, H., Xin, H., Pan, S., Liu, Z., Wang, D., Liu, B., Gao, L., Liu, R., Pang, Y., Chen, X., Zheng, J., & Jin, Q. (2021). Urinary metabolomic analysis to identify potential markers for the diagnosis of tuberculosis and latent tuberculosis. Archives of Biochemistry and Biophysics, 704, 108876.

Dr. Jianhua Zheng advances global infectious disease science through high-impact research on SARS-CoV-2 neutralizing antibodies and tuberculosis biomarkers. His work accelerates diagnostic precision and therapeutic innovation, strengthening global preparedness for emerging pathogens.

Kaiming Zhang | Infectious Disease | Best Scientist in Chronic Infectious Diseases

Published on by Global Diseases Research

Prof. Kaiming Zhang | Infectious Disease | Best Scientist in Chronic Infectious Diseases 

Professor | Shanxi Medical University | China

Prof. Kaiming Zhang is a researcher affiliated with Shanxi Medical University, Taiyuan, China, recognized for his expanding contributions to contemporary biomedical and clinical research. With 111 scientific publications, 896 citing documents, and over 1,300 citations, he has established a sustained scholarly presence reflected in an h-index of 22, demonstrating both productivity and the growing influence of his work. Dr. Zhang’s research portfolio spans multidisciplinary domains within medical science, contributing to the advancement of evidence-based understanding in areas relevant to public health, disease mechanisms, and clinical outcomes. His publications include peer-reviewed journal articles, emerging preprints, and collaborative studies with more than 120 co-authors, underscoring his strong integration within global scientific networks and cross-institutional partnerships. Through this collaborative engagement, Dr. Zhang actively supports the development of innovative methodologies, robust analytical frameworks, and data-driven insights that inform clinical practice and medical policy. His contributions are widely cited, reflecting their relevance across diverse research communities and their application in ongoing scientific progress. Dr. Zhang’s scholarly activities also demonstrate a commitment to scientific transparency and evolving research dissemination, with work represented across Scopus-indexed platforms and linked to ORCID for interoperable academic identity management. Although specific award information is not listed, the breadth and depth of his output underscore his dedication to advancing medical research and strengthening the global exchange of scientific knowledge. Overall, Dr. Kaiming Zhang exemplifies a modern clinician-researcher whose work enhances understanding of critical health challenges and contributes meaningfully to improved patient care, research innovation, and societal well-being.

Profiles: Scopus

Featured Publications

1. He, Y., Xing, J., Li, J., Zhang, K., & Li, X. (2025). S100A8 and S100A9-mediated keratinocyte affecting T lymphocyte immune imbalance through TLR4/NF-κB in psoriasis. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-025-96874-y.

2. Liang, H., Wang, Y., Li, J., & Zhang, K. (2025). Crotonylation deficiency of S100A7 K49 promotes psoriatic keratinocyte proliferation through enhanced interaction with RAGE. Scientific Reports, 15(1), 14678. https://doi.org/10.1038/s41598-025-96874-y.

3. Liang, N., Cao, Y., Li, J., & Zhang, K. (2025). Normal dermal mesenchymal stem cells improve the functions of psoriatic keratinocytes by inducing autophagy. Acta Histochemica, 127(1), 152229. https://doi.org/10.1016/j.acthis.2025.152229.

4. Kuroda, K., Sapadin, A., Shoji, T., Fleischmajer, R., & Lebwohl, M. (2001). Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. Journal of Investigative Dermatology, 116(5), 713–720. https://doi.org/10.1046/j.1523-1747.2001.01316.x.
Cited by 124

Prof. Kaiming Zhang advances the molecular understanding of inflammatory and immune-mediated diseases, uncovering pathways that drive disease progression. His work provides essential foundations for developing targeted therapies and improving clinical outcomes worldwide.

Yanchun Wu | Stroke Care | Research Excellence Award

Published on by Global Diseases Research

Dr. Yanchun Wu | Stroke Care | Research Excellence Award

Associate Chief Nurse | The First Affiliated Hospital of Shantou University Medical College | China

Dr. Yanchun Wu, affiliated with The First Affiliated Hospital of Shantou University Medical College in China, is an emerging clinician-researcher contributing to the fields of cardiothoracic surgery, perioperative care, and critical-care risk assessment. With 6 scientific publications, 50 citations, and an h-index of 3, Dr. Wu’s work reflects growing influence within a specialized but high-impact research domain. His recent open-access study on the Dynamic Modified Early Warning Score (DMEWS) for predicting postoperative mortality in acute type A aortic dissection exemplifies his focus on improving clinical decision-making, advancing prognostic accuracy, and enhancing survival outcomes in high-risk cardiovascular patients. Dr. Wu frequently collaborates with multidisciplinary teams across surgery, emergency medicine, and data-driven clinical modeling, fostering shared expertise and methodological rigor. His publications collectively address postoperative monitoring, surgical outcomes, and predictive analytics, contributing to evidence-based improvements in hospital practice. Through these efforts, Dr. Wu’s research supports more precise risk stratification and earlier intervention strategies, ultimately strengthening patient safety and reducing postoperative complications. Although early in his academic career, his growing collaboration network and consistent contributions signal long-term potential for significant advancements in cardiothoracic care and clinical prognostics.

Profiles: Scopus | ORCID

Featured Publications

1. Lin, D., Ying, W., Zhang, H., Xiu, Y., Li, E., Zheng, R., & Wu, Y. (2025). Comprehensive need as a mediator between psychological stress and quality of life among caregivers of patients with cancer. Cancer Nursing, 48(4), E216–E222.

2. Wu, Y., Guo, Y., Xu, N., Zhang, H., Xiu, Y., Lin, D., & Ying, W. (2023). Risk factors for post-traumatic stress disorder in nurses from the regional medical alliance during the COVID-19 epidemic: A prospective cross-sectional study. Heliyon, 9(10), e20289.

Dr. Yanchun Wu advances critical-care and cardiovascular medicine through data-driven research that improves early risk detection and postoperative outcomes. His work strengthens clinical decision-making and enhances patient survival, contributing meaningful innovations to global health practice.

Yi Zhang | Children Oncology | Excellence in Research Award

Published on by Global Diseases Research

Prof. Yi Zhang | Children Oncology | Excellence in Research Award 

Chief of department of pediatric | Capital Medical University | China

Dr. Yi Zhang is a dedicated clinician-researcher at Beijing Chao-Yang Hospital, Capital Medical University, recognized for impactful contributions at the intersection of infectious diseases, drug safety, and clinical therapeutics. With 35 peer-reviewed publications and over 465 citations, Dr. Zhang has established a strong scholarly footprint supported by extensive collaborations with more than 100 co-authors, reflecting an active role in multidisciplinary and multinational research networks. His recent work includes real-world evaluations of antiviral therapies, such as comparative analyses of Simnotrelvir-Ritonavir versus Nirmatrelvir-Ritonavir during the Omicron EG.5 surge, offering timely evidence to guide treatment strategies in evolving pandemic conditions. Dr. Zhang’s investigations into thrombotic microangiopathy linked to calcineurin inhibitors and thromboembolic or bleeding risks associated with angiogenesis inhibitors further highlight his commitment to advancing pharmacovigilance and patient safety in high-risk clinical populations. His broader research portfolio spans drug-related adverse events, therapeutic optimization, and outcomes research, contributing to improved clinical decision-making and enhanced healthcare quality. Dr. Zhang’s work holds clear societal relevance, particularly in informing evidence-based policies and strengthening clinical readiness for emerging infectious threats. Backed by a growing citation record and a solid h-index of 13, he continues to shape scientific discourse through rigorous methodology, collaborative engagement, and a focus on translating data into meaningful improvements in patient care.

Profiles: Scopus | ORCID

Featured Publications

1. Zhang, Y., Zhu, Y., Yang, H., Jiang, C., Chen, W., Zhang, H., Zhang, X., Wu, H., Li, J., & An, Z.-l. (2025). Efficacy and Safety of Simnotrelvir-Ritonavir Compared With Nirmatrelvir-Ritonavir in the Treatment of COVID-19: Real-World Evidence From a Retrospective Cohort Study During the Prevalence of the Omicron EG.5 Variant. Clinical Therapeutics.  cited by 1.

2. Wang, Y., Ma, Z., An, Z., Zhang, Y., Feng, X., Yu, X. (2023, February). Risk of cutaneous adverse events in cancer patients treated with phosphatidylinositol-3-kinase inhibitors: A systematic review and meta-analysis of randomized controlled trials. Cancer Medicine. cited by 1.

Jaime Perrna Ortiz | Climate-Linked Diseases | Research Excellence Award

Published on by Global Diseases Research

Dr. Jaime Perrna Ortiz | Climate-Linked Diseases | Research Excellence Award 

Professor | University of Malaga | Spain

Dr. Jaime Pereña-Ortiz is a researcher affiliated with the Universidad de Málaga, Spain, recognized for his contributions to environmental conservation, plant ecology, and the long-term management of vulnerable Mediterranean species. His scholarly work, comprising 16 peer-reviewed publications and more than 60 citations, reflects a focused expertise in biodiversity assessment, ecological monitoring, and sustainable habitat restoration strategies. Through his research, Dr. Pereña-Ortiz has explored critical ecological challenges affecting the south-eastern Iberian Peninsula, with particular emphasis on threatened species such as Maytenus senegalensis subsp. europaea, where he has contributed to integrated management frameworks designed to reverse decades of decline. His collaborative footprint spans over 70 co-authors, demonstrating a strong engagement with multidisciplinary teams across ecology, environmental sciences, conservation policy, and ecosystem management. Dr. Pereña-Ortiz’s research emphasizes evidence-based conservation planning, combining field surveys, ecological diagnostics, and adaptive management approaches to support land-use decision-making and regional biodiversity protection. Beyond academic metrics, the societal impact of his work lies in informing conservation authorities, guiding habitat recovery initiatives, and providing scientific foundations essential for safeguarding rare Mediterranean flora under increasing climatic and anthropogenic pressures. His studies contribute to enhanced ecological resilience, improved conservation outcomes, and broader understanding of species persistence in semi-arid environments. As a committed conservation scientist, Dr. Pereña-Ortiz continues to advance research that bridges scientific inquiry with practical environmental solutions, supporting the long-term preservation of ecologically significant landscapes within Spain and the broader Mediterranean region.

Profiles: Scopus | Google Scholar

Featured Publications

1. Hammana, C., Pereña-Ortiz, J. F., Meddad-Hamza, A., Hamel, T., … (2024). The Wetlands of Northeastern Algeria (Guelma and Souk Ahras): Stakes for the Conservation of Regional Biodiversity. Land, 13(2), 210.
Cited by: 9

2. Gil-Leguizamón, P. A., Pereña-Ortiz, J. F., Sánchez-Mata, D., Salvo-Tierra, Á. E., … (2024). Spatial and Temporal Dynamics of the Vegetation Cover from the Bijagual Massif, Boyacá, Colombia, during the 1986–2021 Period. Plants, 13(7), 948.
Cited by: 4

3. Pereña-Ortiz, J. F., Salvo-Tierra, Á. E., & Sánchez-Mata, D. (2023). Application of phytosociological information in the evaluation of the management of protected areas. Plants, 12(2), 406.
Cited by: 4

4. Salvo Tierra, Á. E., Pereña Ortiz, J., Cortes-Molino, Á., Rodríguez Rodríguez, D., … (2020). Modelo de evaluación de la efectividad, continuidad y conectividad del sistema de áreas protegidas costeras mediante el análisis de su flora y vegetación. Universidad Complutense de Madrid.
Cited by: 3

5. Pereña-Ortiz, J. F., Salvo-Tierra, Á. E., Cozano-Pérez, P., & Ruiz-Valero, Á. (2025). Propagating uncertainty in urban tree trait measurements to estimate socioeconomic inequities in ecosystem service accessibility: A machine learning and simulation framework. Environmental and Sustainability Indicators, 100864.
Cited by: 1

Dr. Jaime Pereña-Ortiz advances conservation science through integrated ecological research that guides the protection of threatened Mediterranean species and habitats. His work strengthens evidence-based biodiversity management, informing sustainable strategies for ecosystems facing long-term environmental pressures. His vision promotes resilient landscapes where science-driven stewardship safeguards regional and global natural heritage.

Pere Domingo | Antiretroviral Therapy | Best Researcher Award

Published on by Global Diseases Research

Prof. Dr. Pere Domingo | Antiretroviral Therapy | Best Researcher Award 

Senior Consultant | Hospital de la Santa Creu i Sant Pau | Spain

Prof. Dr. Pere Domingo is an internationally recognized clinician-scientist at the Hospital de la Santa Creu i Sant Pau in Barcelona, Spain, with an extensive research portfolio spanning HIV medicine, viral immunology, infectious diseases, and long-term treatment outcomes in people living with HIV. With 727 scientific publications and more than 21,600 citations from over 17,300 citing documents, he has made sustained and influential contributions to the field, reflected in an h-index of 68. His work integrates clinical trials, epidemiological modeling, translational immunology, and therapeutic optimization to advance understanding of HIV pathogenesis, comorbidities, and treatment simplification strategies. Recent publications include studies on HIV vaccine immunogenicity, cardiovascular risk disparities between HIV-positive individuals and the general population, antiretroviral therapy de-escalation, vaccine responsiveness in immunocompromised groups, immune biomarkers associated with cardiovascular injury, and longitudinal body composition outcomes following regimen switches. His collaborations extend across more than 9,000 co-authors, illustrating his role as a major contributor to large, multicentric, and interdisciplinary research networks in Europe and globally. Dr. Domingo’s work emphasizes improving patient quality of life, reducing treatment toxicity, optimizing therapeutic combinations, and enhancing immune recovery in vulnerable populations, including kidney transplant recipients and those with complex comorbidities. His scholarly output also includes high-impact reviews on HIV-associated lipodystrophy, lymphoproliferative disorders, and historical perspectives on infectious diseases, demonstrating a broad conceptual engagement with both modern and classical dimensions of disease. Through rigorous clinical investigation, leadership in multicenter trials, and sustained contributions to evidence-based HIV management, Dr. Domingo has significantly shaped current approaches to antiretroviral therapy, chronic disease monitoring, and long-term care strategies, reinforcing his standing as a leading figure in contemporary HIV and infectious disease research.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. A., … (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. The Lancet, 362(9377), 22–29. Cited by: 1661

2. Smith, C. J., Ryom, L., Weber, R., Morlat, P., Pradier, C., Reiss, P., Kowalska, J. D., … (2014). Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration. The Lancet, 384(9939), 241–248. Cited by: 1220

3. Knobel, H., Alonso, J., Casado, J. L., Collazos, J., González, J., Ruiz, I., … (2002). Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA Study. AIDS, 16(4), 605–613.
Cited by: 729

Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award

Published on by Global Diseases Research

Dr. Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award 

Lecturer | Univeristy of the Witwatersrand | South Africa

Dr. Raeesa Manjoo-Docrat is a developing scholar affiliated with the University of the Witwatersrand, Johannesburg, whose work contributes to the advancement of quantitative epidemiology and public health modelling in South Africa. Her research focuses on the development and application of spatial, age-stratified epidemiological models aimed at understanding disease transmission dynamics within heterogeneous populations. With four peer-reviewed publications and 27 citations, she has established a growing academic footprint supported by an h-index of 2, reflecting the early but significant influence of her work. Her recent open-access article in Heliyon (2025), which applies spatial modelling frameworks to the South African COVID-19 pandemic, exemplifies her commitment to integrating mathematical rigor with real-world public health challenges. Manjoo-Docrat has collaborated with multidisciplinary teams comprising epidemiologists, mathematicians, and public health scientists, enabling her to contribute to robust analytical frameworks and high-quality scientific outputs. These collaborations also highlight her ability to operate effectively within diverse research environments and to engage in evidence-based problem solving that supports both academic and policy-relevant outcomes. Her research sits at the intersection of infectious disease dynamics, health systems planning, and data-driven decision support, positioning her work within a globally relevant domain of applied epidemiology. Beyond academic metrics, her contributions have societal impact by informing approaches to epidemic preparedne  ss, guiding interventions for vulnerable demographic groups, and enhancing understanding of spatial disparities in health outcomes. Through her continued scholarship, Manjoo-Docrat aims to strengthen the integration of mathematical modelling into national and regional public health strategies, ensuring that data-informed insights contribute to improved health resilience and equitable disease control.

Profiles: Scopus | ORCID

Featured Publications

1. Manjoo-Docrat, R., Abdelatif, N., Holloway, J., Dudeni-Tlhone, N., Dresselhaus, C., Mbayise, E., … Makhanya, S. (2025). Spatial age-stratified epidemiological model with applications to South African COVID-19 pandemic. Heliyon, 11(11), e43171. https://doi.org/10.1016/j.heliyon.2025.e43171

2. Dresselhaus, C., Fabris-Rotelli, I., Manjoo-Docrat, R., Brettenny, W., Holloway, J., Thiede, R., Debba, P., & Dudeni-Tlhone, N. (2023). A spatial model with vaccinations for COVID-19 in South Africa. Spatial Statistics, 58, Article 100792. Cited by 2.

3. Manjoo-Docrat, R. (2022). A spatio-stochastic model for the spread of infectious diseases. Journal of Theoretical Biology, 533, 110943.  Cited by 16.

4. Fabris-Rotelli, I., Holloway, J., Kimmie, Z., Archibald, S., Debba, P., Manjoo-Docrat, R., … Potgieter, A. (2022). A Spatial SEIR Model for COVID-19 in South Africa. Journal of Data Science, Statistics, and Visualisation, 2(7), 14–45.  Cited by 5.

Qingfeng Zhang | Echocardiography | Best Researcher Award

Published on by Global Diseases Research

Dr. Qingfeng Zhang | Echocardiography | Best Researcher Award 

Doctor | University of Electronic Science and Technology of China | China

Dr. Qingfeng Zhang is a dedicated researcher at the University of Electronic Science and Technology of China, contributing significantly to the rapidly advancing fields of millimeter-wave engineering, silicon-based phased arrays, and next-generation integrated circuit technologies. With a body of 38 publications and over 100 citations, his work reflects both technical depth and sustained scholarly influence. His research focuses on high-frequency system design, advanced CMOS on-chip antennas, and innovative 3D packaging architectures, emphasizing improved circuit modeling, miniaturization, and performance optimization for emerging communication systems. Dr. Zhang’s studies on silicon-based millimeter-wave integrated phased arrays and device-to-system modeling address foundational engineering challenges that are critical to the development of 5G, 6G, and high-speed sensing technologies. His contributions to improved equivalent circuit models, high-gain compact D-band antennas, and enhanced interconnection structures demonstrate his commitment to bridging theoretical modeling with practical device implementation. Collaborating with more than 80 international and domestic co-authors, he is actively engaged in multidisciplinary research that advances semiconductor reliability, packaging innovation, and electromagnetic design. His work not only supports the academic community but also carries significant societal impact by informing the development of faster, more efficient, and more reliable wireless systems that underpin modern communication infrastructures. With an h-index of 6 and growing recognition within the engineering research community, Dr. Zhang continues to build a strong scholarly profile centered on technological innovation, collaborative inquiry, and practical solutions to next-generation communication challenges.

Profiles: Scopus

Featured Publications

1. Zhang, Q., Liu, H., Yu, Y., Wu, Y., Zhao, C., Zhang, J., & Kang, K. (2025). Developments and challenges of silicon-based millimeter-wave integrated phased arrays: System, circuit, and device modeling. Science China Information Sciences, 68, Article 1914015.

2. Li, Y., Zhang, Q., Tang, H., Yang, Y., & Kang, K. (2025, May). A D-band CMOS on-chip antenna with high gain and miniaturization. In Proceedings of the 2025 IEEE MTT-S International Wireless Symposium (IWS) (conference paper).

3. Liu, Y., Wang, H., et al. (2025, May). Improved equivalent circuit model of BGA and RDL combined interconnection for 3D packaging. In Proceedings of the 2025 IEEE MTT-S International Wireless Symposium (IWS). Cited by: 1)

Dr. Qingfeng Zhang’s work in silicon-based millimeter-wave integrated phased arrays and advanced 3D packaging technologies is advancing the next generation of high-frequency communication, sensing, and semiconductor innovation. His contributions strengthen the scientific foundation for faster, more efficient, and scalable wireless systems, supporting progress in global connectivity, smart industries, and emerging 6G technologies.

Tayebeh Roghani | Non-Communicable Diseases | Editorial Board Member

Published on by Global Diseases Research

Assist. Prof. Dr. Tayebeh Roghani | Non-Communicable Diseases | Editorial Board Member

Assistant Professor | Isfahan University of Medical Sciences | Iran

Assist. Prof. Dr. Tayebeh Roghanii is an accomplished researcher at the Isfahan University of Medical Sciences whose work has contributed significantly to advancing biomedical and public health knowledge. With a portfolio of 15 peer-reviewed publications and over 236 citations across 216 citing documents, she has established a strong scholarly presence marked by methodological rigor and interdisciplinary depth. Her research spans critical areas of medical science, reflecting a sustained commitment to improving clinical outcomes and informing evidence-based practice. Through collaborations with more than 40 co-authors, she has engaged in diverse scientific networks, enriching her work with multidisciplinary insights and contributing to broader scientific discourse. Her h-index of 7 underscores both the productivity and influence of her scholarship within the global research community. Roghani’s contributions demonstrate a focus on generating impactful evidence that supports better decision-making in healthcare systems, enhances disease understanding, and addresses emerging medical challenges. Her scientific output also reflects a dedication to mentoring and collaborative teamwork, reinforcing the importance of shared expertise in advancing health research. As her work continues to gain recognition, she stands out as a committed academic whose research provides meaningful societal value by informing clinical guidelines, shaping public health strategies, and strengthening the scientific foundation necessary for improving patient care and population health outcomes.

Profiles: ORCID | Scopus

Featured Publications

1. Ghomash Baf Zadeh, R., Roghani, T., Gladin, A., Katzman, W. B., Bokaee, F., & Adibi, P. (2025). Spinal‐Related Musculoskeletal Determinants of Functional Abdominal Bloating and Distension: A Narrative Review. Health Science Reports, 8(7).  Cited by 23.

2. Roghani, T., Allen, D. D., Gladin, A., Rahimi, A., Mehrabi, M., Rezaeian, Z. S., Farajzadegan, Z., & Katzman, W. B. (2024). The association between physical function and hyperkyphosis in older females: A systematic review and meta-analysis. Journal of Geriatric Physical Therapy, 47(2), 85-96.  Cited by 11.

3. Roghani, T., Gladin, A., Talebian, S., Khalkhali Zavieh, M., Niknam, H., & Katzman, W. B. (2022). Sagittal spinal mobility and back extensor muscle function in older females with age-related hyperkyphosis. Journal of Modern Rehabilitation, 16(2). https://doi.org/10.18502/jmr.v16i2.9306. — Cited by 1.

4. Mahmoodiaghdam, S., Nodehi, M., Aryanfar, H., Roghani, T., Baghban, A. A., & Khalkhali Zavieh, M. (2024). Investigating the difference between thoracic kyphosis and its mobility in community-dwelling older men and women. Journal of Modern Rehabilitation, 18(3), 310-316.

Assist. Prof. Dr. Tayebeh Roghani advances scientific understanding of musculoskeletal health, aging, and rehabilitation through evidence-based research and interdisciplinary collaboration. Her work strengthens clinical practice by generating insights that enhance functional outcomes and quality of life for diverse patient populations. She envisions a future where accessible, data-driven rehabilitation strategies improve global well-being.

Hao Phan | Cardiovascular Medicine | Best Researcher Award

Published on by Global Diseases Research

Dr. Hao Phan | Cardiovascular Medicine | Best Researcher Award 

Lecturer | Pham Ngoc Thach University of Medicine | Vietnam

Dr. Hao Thai Phan is an emerging medical researcher affiliated with the University of Medicine and Pharmacy, Hue University, Viet Nam, whose work reflects a focused commitment to advancing diagnostic science and improving clinical outcomes, particularly in the field of nephrology and cardiorenal interactions. With a developing but impactful research portfolio, he has contributed three peer-reviewed publications that have collectively earned 15 citations, demonstrating growing recognition of his scholarly work within the international medical community. His notable study on the diagnostic value of plasma NGAL in cardiorenal syndrome type 1, published in the Electronic Journal of General Medicine, highlights his expertise in utilizing novel biomarkers to enhance early detection and management of complex cardiorenal conditions. Dr. Phan’s research interests span clinical diagnostics, internal medicine, and interdisciplinary approaches to kidney–heart pathophysiology, as reflected in collaborations with nine co-authors from diverse medical specialties. His work aligns with global efforts to strengthen evidence-based practice in low- and middle-income healthcare settings, focusing on improving accessibility to reliable diagnostic tools and elevating patient care standards. Although early in his academic career, he has begun to establish a foundation for long-term contributions to translational research, integrating laboratory insights with real-world clinical needs. His engagement with collaborative networks further reinforces his role as a developing scholar dedicated to addressing critical health challenges in Viet Nam and beyond. Through his growing publication record, commitment to biomarker research, and interdisciplinary partnerships, Dr. Phan is progressively shaping a research trajectory that supports enhanced clinical decision-making, fosters innovation in disease detection, and contributes to the broader scientific mission of improving health outcomes across the Asia-Pacific region.

Profiles: Scopus | Google Scholar | ORCID

1. Huynh, P. K., Setty, A., Phan, H., & Le, T. Q. (2021). Probabilistic domain-knowledge modeling of disorder pathogenesis for dynamics forecasting of acute onset. Artificial Intelligence in Medicine, 115, 102056.
Cited by: 20

2. Phan, H. T., Hoang Bui, B., Hoang Anh, T., & Huynh Van, M. (2020). Value of plasma NGAL and creatinine on first day of admission in the diagnosis of cardiorenal syndrome type 1. Cardiology Research and Practice, 2020(1), 2789410.
Cited by: 15

3. Hanh, D. L. M., Hao, P. T., & Tho, N. V. (2023). Risk factors related to the death of admitted COVID-19 patients: A Buffalo study. The Open Respiratory Medicine Journal, 17, e187430642302200.
Cited by: 4

4. Phan, T. H., Phan, D. Q., Nguyễn, V. T., & Phan, M. H. (2022). Đặc điểm lâm sàng, cận lâm sàng BN COVID-19 nhập viện. Tạp chí Y học Việt Nam, 517(1).
Cited by: 3

5. Phan, H. T. (2018). Non-compaction cardiomyopathy misdiagnosed as dilated cardiomyopathy. Journal of Case Reports, 8(1), 10–13.
Cited by: 3

Dr. Hao Thai Phan’s research advances early diagnostics in critical care by improving biomarker-based detection of cardiorenal syndrome, enabling faster and more accurate clinical decision-making. His work contributes to strengthening patient outcomes in resource-limited settings and supports global innovation in precision medicine and acute care management.